首页> 外国专利> PROCESS FOR THE PREPARATION OF A BASIC WATER-SOLUBLE ANTIBIOTIC BY GROWING A MICRO-ORGANISM OF THE GENDER MICROMONOSPORA UNDER APPROPRIATE CONDITIONS, AS WELL AS A METHOD OF PREPARATION OF A PHARMACEUTICAL ANTIBIOTIC APPLICATION ANTIBIOTIC APPLICATION METHOD TO BRING.

PROCESS FOR THE PREPARATION OF A BASIC WATER-SOLUBLE ANTIBIOTIC BY GROWING A MICRO-ORGANISM OF THE GENDER MICROMONOSPORA UNDER APPROPRIATE CONDITIONS, AS WELL AS A METHOD OF PREPARATION OF A PHARMACEUTICAL ANTIBIOTIC APPLICATION ANTIBIOTIC APPLICATION METHOD TO BRING.

机译:在适当的条件下通过生长微小线虫的微生物来制备碱性的水溶性抗生素的方法,以及制备药学上抗菌的抗生素的方法。

摘要

1,274,518. Antibiotic 66-40. SCHERICO Ltd. 24 June, 1969 [27 June, 1968; 16 Dec., 1968], No. 31887/69. Heading C2A. Novel Antibiotic 66-40 having the formula and characterized as being a basic pseudooligosaccharide having the following properties: elemental analysis, C = 49À80, H = 8À20, N = 14À95 and 0=27À05; molecular weight 447À26; empirical formula C 19 H 37 N 5 O 7 .H 2 O; melting point 185-190‹ C.; equivalent weight 92; pKa 8À0; []SP26‹/SP D + 188À9‹ (C = 0À3% in H 2 O); U.V. absorption: transparent between 220 and 440 mÁ; I.R. absorption peaks at 2À98, 3À05, 3À16, 3À35- 3À50 (mull), 5À93, 6À25, 6À82 (mull), 7À25 (mull), 8À77, 9À00, 9À47, 9À72-10À07, 10À46, 11À97, 12À75 and 13À45-13À90 Á; and forming hydrates and other solvates, condensation products with aldehydes and ketones and salts with acids, is prepared by aerobically cultivating Micromonospora inyoensis (NRRL 3292). The condensation products, which are probably Schiff bases, are formed by reacting 66-40 with aldehydes and/or ketones such as acetaldehyde, acetone, methyl - ethyl - ketone, crotonaldehyde, furfural, cyclopentylacetaldehyde, vanillin, veratraldehyde, benzophenone, benzaldehyde, acetophenone, salicylaldehyde and pyridoxal. Antibiotic 66-40 has bacteriostatic activity on Gram-positive and Gram-negative bacteria and Rickettsia. Pharmaceutical compositions comprise the antibiotic 66-40 or its acid addition salts or aldehyde or ketone condensation products together with a pharmaceutically acceptable carrier or diluent, and may be in forms for topical, oral or parenteral administration.
机译:1,274,518。抗生素66-40。 SCHERICO Ltd.,1969年6月24日[1968年6月27日; [1968年12月16日],第31887/69号。标题C2A。具有以下分子式并被表征为碱性伪低聚糖的新型抗生素66-40,具有以下特性:元素分析,C = 49‑80,H = 8‑20,N = 14‑95和0 = 27‑05;分子量447À26;经验式C 19 H 37 N 5 O 7 .H 2 O;熔点185-190℃。当量重量92; pKa 8‑0; [] 26 ‹< / SP> D + 188‑9 ‹(在H 2 O中C = 0‑3%); U.V.吸收率:在220至440mÁ之间透明; I.R.吸收峰位于2‑98、3‑05、3‑16、3‑35-3‑50(马尔),5‑93、6‑25、6‑82(马尔),7‑25(马尔),8‑77、9‑00、9‑47、9‑72-10‑07、10‑46、11‑97、12‑75和13‑45-13‑90阿;通过有氧培养小单孢厌氧菌(NRRL 3292)制备水合物和其他溶剂化物,与醛和酮的缩合产物以及与酸的盐。缩合产物可能是席夫碱,是通过66-40与醛和/或酮(例如乙醛,丙酮,甲基-乙基-酮,巴豆醛,糠醛,环戊基乙醛,香草醛,藜芦醛,二苯甲酮,苯甲醛,苯乙酮)反应形成的,水杨醛和吡ido醛。抗生素66-40对革兰氏阳性和革兰氏阴性细菌和立克次体具有抑菌活性。药物组合物包含抗生素66-40或其酸加成盐或醛或酮缩合产物以及药学上可接受的载体或稀释剂,并且可以呈局部,口服或肠胃外给药的形式。

著录项

  • 公开/公告号NL6909642A

    专利类型

  • 公开/公告日1969-12-30

    原文格式PDF

  • 申请/专利权人

    申请/专利号NL19690009642

  • 发明设计人

    申请日1969-06-24

  • 分类号C12D9/14;

  • 国家 NL

  • 入库时间 2022-08-23 11:33:50

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号